Fezolinetant, also known as ESN-364, is Neurokinin-3 (NK-3) receptor antagonist which has been optimized for use in women’s health, and is being developed for sex-hormone related disorders such as endometriosis, polycystic ovarian syndrome and uterine fibroids.
仅供研究使用。 我们不向患者出售。
名称 | Fezolinetant |
---|---|
Iupac 化学名称 | (R)-(4-fluorophenyl)(8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone |
同义词 | Fezolinetant ; ESN-364 ; ESN 364 ; ESN364 |
英文同义词 | Fezolinetant ; ESN-364 ; ESN 364 ; ESN364 |
分子式 | C16H15FN6OS |
分子量 | 358.3954 |
Smile | O=C(C1=CC=C(F)C=C1)N2[C@H](C)C3=NN=C(C4=NC(C)=NS4)N3CC2 |
InChiKey | PPSNFPASKFYPMN-SECBINFHSA-N |
InChi | InChI=1S/C16H15FN6OS/c1-9-13-19-20-14(15-18-10(2)21-25-15)23(13)8-7-22(9)16(24)11-3-5-12(17)6-4-11/h3-6,9H,7-8H2,1-2H3/t9-/m1/s1 |
Cas号 | 1629229-37-3 |
相关CAS号 | 1629229-37-3 |
包装 | 价格 | 库存 | 纯度 | 备货期 |
---|---|---|---|---|
大货 | 询价 | 询价 | 询价 |
外观性状 | Off-white solid to white solid |
---|---|
纯度 | >98% |
存储 | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
可溶性 | Soluble in DMSO |
处理方式 | |
运输条件 | Shipped under ambient temperature |
海关编码 |
Targets | Neurokinin-3 (NK-3) receptor antagonist |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |
1: Fraser GL, Ramael S, Hoveyda HR, Gheyle L, Combalbert J. The NK3 Receptor Antagonist ESN364 Suppresses Sex Hormones in Men and Women. J Clin Endocrinol Metab. 2016 Feb;101(2):417-26. doi: 10.1210/jc.2015-3621. Epub 2015 Dec 14. PubMed PMID: 26653113.
2: Fraser GL, Hoveyda HR, Clarke IJ, Ramaswamy S, Plant TM, Rose C, Millar RP. The NK3 Receptor Antagonist ESN364 Interrupts Pulsatile LH Secretion and Moderates Levels of Ovarian Hormones Throughout the Menstrual Cycle. Endocrinology. 2015 Nov;156(11):4214-25. doi: 10.1210/en.2015-1409. Epub 2015 Aug 25. PubMed PMID: 26305889.